Julien Dagher

1.1k total citations
23 papers, 509 citations indexed

About

Julien Dagher is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Julien Dagher has authored 23 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Julien Dagher's work include Renal cell carcinoma treatment (11 papers), Renal and related cancers (11 papers) and Cancer Genomics and Diagnostics (5 papers). Julien Dagher is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Renal and related cancers (11 papers) and Cancer Genomics and Diagnostics (5 papers). Julien Dagher collaborates with scholars based in France, Switzerland and Australia. Julien Dagher's co-authors include Marc‐Antoine Belaud‐Rotureau, Frédéric Dugay, Alexandra Lespagnol, Nathalie Rioux‐Leclercq, Hemamali Samaratunga, Lars Egevad, Brett Delahunt, John Yaxley, Florian Cabillic and Karim Bensalah and has published in prestigious journals such as Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Julien Dagher

23 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julien Dagher France	12	375	216	179	125	90	23	509
Jun Kang South Korea	15	160 0.4×	198 0.9×	243 1.4×	124 1.0×	138 1.5×	52	550
Takayuki Takahama Japan	14	267 0.7×	125 0.6×	265 1.5×	150 1.2×	41 0.5×	45	473
Irene Sansano Spain	14	336 0.9×	161 0.7×	285 1.6×	234 1.9×	52 0.6×	47	737
Masashi Mikubo Japan	12	256 0.7×	119 0.6×	213 1.2×	96 0.8×	37 0.4×	40	458
Shengming Jin China	13	165 0.4×	290 1.3×	74 0.4×	210 1.7×	58 0.6×	32	481
Robert Weaver United States	5	381 1.0×	88 0.4×	295 1.6×	72 0.6×	83 0.9×	8	545
Fabiana Bettoni Brazil	15	149 0.4×	247 1.1×	273 1.5×	173 1.4×	35 0.4×	30	557
Ka‐Won Noh Germany	13	172 0.5×	97 0.4×	204 1.1×	92 0.7×	54 0.6×	22	402
Willemijne A.M.E. Schrijver Netherlands	11	167 0.4×	135 0.6×	286 1.6×	205 1.6×	65 0.7×	13	470
Emily K. Slotkin United States	13	271 0.7×	230 1.1×	213 1.2×	135 1.1×	20 0.2×	38	548

Countries citing papers authored by Julien Dagher

Since Specialization

Citations

This map shows the geographic impact of Julien Dagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Dagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Dagher more than expected).

Fields of papers citing papers by Julien Dagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Dagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Dagher. The network helps show where Julien Dagher may publish in the future.

Co-authorship network of co-authors of Julien Dagher

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Dagher. A scholar is included among the top collaborators of Julien Dagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Dagher. Julien Dagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Banerjee, Susana, Anita Wolfer, Petronella B. Ottevanger, et al.. (2025). Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study. Clinical Cancer Research. 31(11). 2145–2153. 3 indexed citations

Grilj, Veljko, J. F. Pernot, Till T. Böhlen, et al.. (2025). Average Dose Rate is the Major Temporal Beam Structure Parameter for Preserving Murine Intestines With Pulsed Electron FLASH Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 123(2). 593–601. 6 indexed citations

Peters, Max, Julien Dagher, Stefano La Rosa, et al.. (2025). Predicting pathological tumor volume in prostate cancer lesions: A head-to-head comparison of micro-ultrasound vs. MRI. Urologic Oncology Seminars and Original Investigations. 43(6). 398.e15–398.e21. 1 indexed citations

Chong, Chloé, Florian Huber, HuiSong Pak, et al.. (2023). The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer. Nature Cancer. 4(5). 608–628. 48 indexed citations

Rakauskas, Arnas, Julien Dagher, Stefano La Rosa, et al.. (2023). Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocol. World Journal of Urology. 41(11). 3325–3331. 7 indexed citations

Mark, Michael, Sylvie Rusakiewicz, Martin Früh, et al.. (2022). Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study. ESMO Open. 7(3). 100446–100446. 5 indexed citations

Rakauskas, Arnas, Julien Dagher, Stefano La Rosa, et al.. (2022). The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis. Progrès en Urologie. 32(6). 6S26–6S32. 1 indexed citations

Ghisoni, Eleonora, Fabrizio Benedetti, Paula Cunnea, et al.. (2022). 27MO Integrated digital pathology and single-cell analysis identify the spatial and temporal evolution of immune cells networks in epithelial ovarian cancer. Annals of Oncology. 33. S395–S395. 1 indexed citations

Yakkala, Chakradhar, Julien Dagher, Christine Sempoux, et al.. (2021). Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma. Frontiers in Immunology. 12. 695150–695150. 13 indexed citations

10.

Dagher, Julien, et al.. (2019). Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma. Pathology. 51(4). 349–352. 2 indexed citations

11.

Dagher, Julien, Brett Delahunt, Nathalie Rioux‐Leclercq, et al.. (2018). Assessment of tumour‐associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma. Histopathology. 74(2). 284–290. 18 indexed citations

12.

Dagher, Julien, Brett Delahunt, Nathalie Rioux‐Leclercq, et al.. (2017). Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading. Histopathology. 71(6). 918–925. 117 indexed citations

13.

Dagher, Julien, Solène‐Florence Kammerer‐Jacquet, Frédéric Dugay, et al.. (2017). Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(1). 107–115. 14 indexed citations

14.

Yaxley, John, Julien Dagher, Brett Delahunt, et al.. (2017). Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques. World Journal of Urology. 36(1). 15–20. 15 indexed citations

15.

Kammerer‐Jacquet, Solène‐Florence, Angélique Brunot, Guillaume Bouzillé, et al.. (2016). Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype. Clinical Genitourinary Cancer. 15(1). e1–e7. 23 indexed citations

16.

Bergeat, Damien, Michel Rayar, Luc Beuzit, et al.. (2016). An unusual case of adrenocortical carcinoma with liver metastasis that occurred at 23 years after surgery. HepatoBiliary Surgery and Nutrition. 5(3). 265–268. 3 indexed citations

17.

Dagher, Julien, Angélique Brunot, Jean‐Jacques Patard, et al.. (2015). Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up. European Urology Focus. 1(3). 284–290. 24 indexed citations

18.

Cabillic, Florian, Audrey Gros, Frédéric Dugay, et al.. (2014). Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances. Journal of Thoracic Oncology. 9(3). 295–306. 118 indexed citations

19.

Dagher, Julien, Frédéric Dugay, Nathalie Rioux‐Leclercq, et al.. (2014). Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival. Human Pathology. 45(8). 1639–1646. 22 indexed citations

20.

Dagher, Julien, Frédéric Dugay, G. Verhoest, et al.. (2013). Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas. Human Pathology. 44(10). 2106–2115. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact